{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T04:40:05Z","timestamp":1717908005459},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cancergeneticsjournal.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.cancergen.2015.05.028","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T10:26:09Z","timestamp":1432203969000},"page":"428-433","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cryptic insertion of 3\u2032FOXO1 into inverted chromosome arm 2q in the presence of two normal chromosome 13s and 13 small interstitial duplications in a patient with alveolar rhabdomyosarcoma"],"prefix":"10.1016","volume":"208","author":[{"given":"Sarah","family":"Hackman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Calvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Bernreuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengya Wang","family":"Mark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Starnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline R.","family":"Batanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2015.05.028_bib0010","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1200\/JCO.2005.03.4934","article-title":"Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry","volume":"24","author":"Wachtel","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0015","first-page":"986","article-title":"Soft tissue tumors: embryonal rhabdomyosarcoma","volume":"13","author":"Barr","year":"2009","journal-title":"Atlas Genet Cytogenet Oncol Haematol"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0020","first-page":"981","article-title":"Soft tissue tumors: alveolar rhabdomyosarcoma","volume":"13","author":"Barr","year":"2009","journal-title":"Atlas Genet Cytogenet Oncol Haematol"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0025","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1038\/sj.onc.1204599","article-title":"Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma","volume":"20","author":"Barr","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0030","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.5858\/2006-130-1454-RIAACA","article-title":"Rhabdomyosarcomas in adults and children: an update","volume":"130","author":"Parham","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0035","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12253-008-9012-5","article-title":"Rhabdomyosarcoma subtyping by immunohistochemical assessment of myogenin: tissue array study and review of the literature","volume":"14","author":"Morgenstern","year":"2008","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0040","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/modpathol.3880179","article-title":"Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues","volume":"13","author":"Kumar","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/156652407779940440","article-title":"Fusions involving PAX and FOX genes in the molecular pathogenesis of alveolar rhabdomyosarcoma: recent advances","volume":"7","author":"Mercado","year":"2007","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0050","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.2002.03.137","article-title":"PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group","volume":"20","author":"Sorensen","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0055","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/PAS.0000000000000195","article-title":"Myogenin, AP2\u03b2, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma","volume":"38","author":"Rudzinski","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0060","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/sj.leu.2402963","article-title":"Patterns of BCR\/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR\/ABL+ leukemias; incidence and underlying genetic abnormalities","volume":"17","author":"Primo","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0165-4608(94)90093-0","article-title":"Pericentric inversion (2)(p15q35) in an alveolar rhabdomyosarcoma","volume":"78","author":"Sawyer","year":"1994","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0070","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1096-911X(20010201)36:2<259::AID-MPO1063>3.0.CO;2-K","article-title":"Cytogenetic abnormalities in 42 rhabdomyosarcoma: a United Kingdom Cancer Cytogenetics Group study","volume":"36","author":"Gordon","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0075","first-page":"4704","article-title":"Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions","volume":"62","author":"Barr","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0080","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/PAP.0b013e3182a92d0d","article-title":"Classification of rhabdomyosarcoma and its molecular basis","volume":"20","author":"Parham","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0085","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/gcc.20731","article-title":"Recurrent (2;2) and (2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator (NCOA) family","volume":"49","author":"Sumegi","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0090","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrc2091","article-title":"The impact of translocations and gene fusions on cancer causation","volume":"7","author":"Mitelman","year":"2007","journal-title":"Nat Rev"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0095","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1101\/gr.114116.110","article-title":"Large duplications at reciprocal translocation breakpoints that might be the counterpart of large deletions and could arise from stalled replication bubbles","volume":"21","author":"Howarth","year":"2011","journal-title":"Genome Res"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0100","first-page":"690","article-title":"Chromosomal and genetic imbalances in Chinese patients with rhabdomyosarcoma detected by high-resolution array comparative genomic hybridization","volume":"7","author":"Liu","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0105","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/1097-0142(19940415)73:8<2231::AID-CNCR2820730832>3.0.CO;2-E","article-title":"MYCN gene amplification in rhabdomyosarcoma","volume":"73","author":"Driman","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0165-4608(95)00267-7","article-title":"Der(16)t(1;16)(q21;q13) as a secondary change in alveolar rhabdomyosarcoma. A case report and review of the literature","volume":"87","author":"McManus","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0120","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1158\/1078-0432.CCR-10-1302","article-title":"The histone methyltranferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors","volume":"17","author":"Hudlebusch","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0125","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1128\/MCB.15.3.1522","article-title":"The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcoma is a more potent transcriptional activator than PAX3","volume":"15","author":"Fredericks","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2015.05.028_bib0130","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1200\/JCO.2009.26.3814","article-title":"Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma","volume":"28","author":"Williamson","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776215001180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776215001180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T04:22:13Z","timestamp":1717906933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776215001180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S2210776215001180"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2015.05.028","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryptic insertion of 3\u2032FOXO1 into inverted chromosome arm 2q in the presence of two normal chromosome 13s and 13 small interstitial duplications in a patient with alveolar rhabdomyosarcoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2015.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}